H1B Salary Data

Home › Employers › The Research Institute of Fox Chase Cancer Center

The Research Institute of Fox Chase Cancer Center: H-1B salaries and sponsorship

The Research Institute of Fox Chase Cancer Center filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $66,228.

Applications (LCAs)3
Certified3
Employer addressPhiladelphia, PA
H-1B dependent employerNo
Median offered salary$66,228
Middle half of salaries$66,228–$66,228
10th–90th percentile$66,228–$66,228

Does The Research Institute of Fox Chase Cancer Center sponsor H-1B visas?

The Research Institute of Fox Chase Cancer Center filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 7, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Postdoctoral Associate3$66,228

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20233$66,228

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Postdoctoral Associate$66,228
Level I
Philadephia, PAJun 7, 2023Jun 15, 2023Certified
Postdoctoral Associate$66,228
Level I
Philadelphia, PAMay 31, 2023Jun 15, 2023Certified
Postdoctoral Associate$66,228
Level I
Philadelphia, PAMay 24, 2023Jun 15, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).